Vol. 281, Issue 1, H316-H324, July 2001
Nitric oxide generation by isolated descending vasa
recta
Krisitie L.
Rhinehart and
Thomas L.
Pallone
Division of Nephrology, University of Maryland School of
Medicine, Baltimore, Maryland 21201-1595
 |
ABSTRACT |
Nitric oxide (NO) generation by the outer medullary descending vasa
recta (OMDVR) was measured with the fluorescent dye
4,5-diaminofluoroscein (DAF-2) during 30-min incubations. Addition of
0.1 or 1.0 mM L-arginine to the incubation buffer increased
the DAF-2 signal by 8.7 and 13.6% (P = 0.08 and
P < 0.05), respectively. Compared with
L-arginine alone (0.1 mM), bradykinin (BK; 1 × 10
7 M) enhanced the DAF-2 signal by 11.1%
(P < 0.05). The NO synthase inhibitor
N
-nitro-L-arginine methyl ester
(0.1 mM) reversed the BK-stimulated NO generation as measured with
either DAF-2 or by the oxidation of Fe2+ hemoglobin. Using
1 mM 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (tempol), a
cell-permeant superoxide dismutase mimetic, we tested whether reduction
of superoxide anion increases intracellular NO. Tempol increased DAF-2
fluorescence by 12 and 23.3%, respectively, over BK-stimulated or
control vessels. Tempol also vasodilated ANG II (1 × 10
8 M)-preconstricted OMDVR (P < 0.05). We conclude that NO generation by isolated OMDVR can be
increased by L-arginine, that the endothelium-dependent vasodilator BK enhances NO production, and that NO consumption by
superoxide plays a role in the determination of cellular NO concentrations.
microperfusion; kidney; hemoglobin; fura 2; tempol; bradykinin; arginine
 |
INTRODUCTION |
DESCENDING VASA
RECTA (DVR) are small generation resistance vessels that carry
blood from the cortex to the medulla of the kidney. DVR originate as
branches of the juxtamedullary efferent arteriole and traverse the
outer medulla in vascular bundles. The DVR that supply the inner and
outer medulla are radially arranged within the bundles from center to
periphery, respectively. This parallel arrangement strongly suggests
that the DVR distribute and regulate regional blood flow within the
medulla (17, 26). DVR are enveloped by small contractile
cells called pericytes (29) and are lined by a continuous
endothelium. The importance of endothelial secretion of paracrine
mediators to modulate the contractility of adjacent smooth muscle is
well established. Motivated by the importance of nitric oxide (NO) in
the maintenance of medullary perfusion and blood pressure
(9, 16, 18-21, 24, 37, 38), we adapted two methods
for measuring NO production by DVR that were isolated and dissected
from vascular bundles of the outer medulla of the kidney. First, the
probe 4,5-diaminofluoroscein (DAF-2), which increases fluorescence with
covalent modification by NO, was used to monitor NO generation
(5, 13). To corroborate the findings with DAF-2, we
employed a second microincubation scheme to monitor the oxidation of
the Fe2+ (ferrous) to Fe3+ (ferric) hemoglobin
(Hb2+ and Hb3+, respectively) by NO (1,
23). The results verified that isolated DVR generate NO and that
NO production is increased by supplying L-arginine or
stimulating with the endothelium-dependent vasodilator bradykinin (BK).
Reduction of superoxide anion with the cell-permeant superoxide
dismutase mimetic 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (tempol) also increased NO in isolated DVR.
 |
METHODS |
Isolation of outer medullary descending vasa recta.
Kidneys were harvested from Sprague-Dawley rats (70-150 g
body wt; Harlan), sliced, placed in buffer, and maintained on ice at
0-4°C. Outer medullary DVR (OMDVR) were dissected from vascular bundles and transferred to the stage of an inverted microscope as
previously described (25-28). The buffer used for
dissection and the bath in these studies included (in mM) 140 NaCl, 10 NaC2H3O2, 5 KCl, 1.2 MgCl2, 2 Na2HPO4/NaH2PO4, 1 CaCl2, 5 alanine, 5 glucose, and 5 HEPES and 0.5 g/dl of
albumin (pH = 7.4).
Fluorescent detection of NO with diaminofluorescein
diacetate probe.
The nonfluorescent molecule DAF-2 diacetate (DAF-2DA) becomes
weakly fluorescent when loaded into cells via deesterification to form
DAF-2. DAF-2 further increases in fluorescence when it is covalently
modified by NO to yield a triazofluorescein (5, 13). Thus
the fluorescent signal from DAF-2 produces an integrated measure of
local NO concentration ([NO]) within the loaded cells. DAF-2 was
excited at 485 nm using a xenon arc lamp (Photon Technology International; Lawrenceville, NJ). Fluorescent emission was isolated with a band-pass filter at 530 nm (Omega Optical; Brattleboro, VT) and
measured with a photon-counting detection assembly (D104B; Photon
Technology International). Each OMDVR was transferred to the imaging
chamber, where the ends were aspirated into a pair of holding
pipettes that had openings of 10-15 µm. The pipettes and vessel
were positioned using micromanipulators (Instruments Technology and
Machinery; San Antonio, TX) mounted on an inverted microscope (Nikon
Diaphot). The OMDVR were positioned near a thermocouple in the narrow
inlet region of a custom-built chamber. Temperature was maintained with
a feedback system (CN9000A; Omega Engineering; Bridgeport, NJ). The
vessel was warmed to 37°C and loaded for 20 min with 10 µM DAF-2DA
ester. DAF-2 loads into both endothelia and pericytes (see Fig.
1, A-C) and increases
emission at 530 nm during excitation between 450 and 500 nm without a
spectral shift (see Fig. 1D).

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 1.
Loading of the fluorescent dye
4,5-diaminofluoroscein (DAF-2) into isolated outer medullary
descending vasa recta (OMDVR). A-C: paired white light and
fluorescent images show that DAF-2 loads diffusely into the cytoplasm
of endothelial cells as well as pericytes. D: normalized
fluorescent emission from DAF-2 at 530 nm versus excitation wavelength
at 1-min intervals after introduction of 2.5 mM sodium nitroprusside
(SNP) into the bath. In OMDVR, DAF-2 increased in fluorescence but did
not undergo a spectral shift.
|
|
Measurement of NO generation with oxyhemoglobin.
As a second method to verify NO generation by isolated OMDVR, we
employed the property of NO to oxidize Hb from the Hb2+
form to the Hb3+ form (1, 23). When this
oxidation occurs, the absorption spectrum of Hb shifts, thereby
permitting a measure of the extent of the oxidation. A microincubation
scheme was devised to take advantage of this property. To serve as a
cuvette for monitoring the conversion of Hb2+ by isolated
OMDVR, a standard microperfusion-style holding pipette was created but
markedly enlarged to ~2 mm in length and ~75 µm in diameter. The
cuvette tip was heat polished to reduce the diameter of the entrance to
~50 µm. Light was passed from a fiber-optic filament through the
cuvette as shown in Fig. 2. The 250-µm
fiber-optic filament (Edmond Scientific; Barrington, NJ) was modified
by drawing it out under heat on a microforge (Stoelting; Wood Dale, IL)
and cutting the taper with a razor blade to obtain a tip diameter of
~50 µm. The end of a length of stainless steel music wire (Small Parts; Miami Lakes, FL) was then polished to a mirror finish with 0.3-µm grit sandpaper (Thomas Scientific; Swedesboro, NJ) and held at
a 30° angle to reflect the transmitted light to the microscope objective. The light collected by the objective was measured with a
photon-counting photomultiplier detection assembly (Photon Technology International) attached to the side port of the microscope. A coupling
was machined from aluminum that permitted insertion of the far end of
the filament into the exit slit of a computer-controlled monochrometer
(Photon Technology International). Thus the wavelength of light for the
measurement of transmittance could be continuously varied as the
transmission through the microcuvette was monitored. In place of a
standard perfusion pipette, the fiber-optic filament was fixed to a
standard acrylic perfusion-pipette holding assembly (Instruments
Technology Machinery; San Antonio, TX) so that it could be advanced in
and out of the constriction by turning a screw. The filament tip was
withdrawn as needed to allow aspiration of buffer containing Hb or
several OMDVR into the cuvette area. When replaced into the
constriction, the fiber-optic tip provided a good seal that prevented
movement of buffer in and out of the cuvette.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
Microincubation for measurement of nitric oxide (NO)
production with hemoglobin (Hb). A cuvette for measurement of light
transmittance was constructed on the end of a microperfusion-style
holding pipette. Nominal dimensions of the cuvette: diameter, 75 µm;
length, 2 mm; opening and constriction, 50 µm. Isolated OMDVR were
drawn into the cuvette area with unreacted Fe2+ Hb
(Hb2+; 5 µM). The conversion of Hb2+ to
Fe3+ Hb (Hb3+) by NO was measured as the change
in transmittance at 420 nm. Light was reflected from the end of a
mirror-polished stainless steel wire to a microscope objective and then
to a photomultiplier assembly.
|
|
The pipette assembly shown in Fig. 2 was used to incubate vessels at
37°C in the same incubation chamber as was used for the DAF-2
fluorescent studies (see Fluorescent detection of NO with diaminofluorescein diacetate probe). Our standard dissection
buffer without albumin that contained specified concentrations of Hb (Sigma) was used as the bath. To initiate a measurement, groups of
3-5 OMDVR (~1 mm long) and unreacted Hb2+ (5 µM;
oxygen saturated by equilibration with room air) were aspirated into
the cuvette, after which the constriction was sealed (by advancing the
optical fiber). To measure NO generation, transmittance through the
2-mm light path in the cuvette was monitored after the light was
quickly blocked from the microscope illuminator. At the end of the
experiment, buffer without Hb was drawn into the cuvette to obtain the
equivalent blank.
Measurement of endothelial intracellular
Ca2+.
The OMDVR were loaded with the Ca2+-sensitive fluorescent
indicator fura 2 by exposure to a bath containing 2 µM fura
2-acetoxymethyl ester (Molecular Probes; Eugene, OR) for 20 min
(25, 27). We have previously shown (25) that
fura 2 preferentially loads into endothelial cells rather than
pericytes. For measurement of intracellular Ca2+
concentration ([Ca2+]i), fura 2-loaded OMDVR
were excited using 350- and 380-nm dual-wavelength combinations. The
background-subtracted ratio of fluorescent emission (R350/380) was calculated for conversion to the equivalent
[Ca2+]i assuming a dissociation constant for
fura 2 at 37°C of 224 nM. The ratio when fura 2 is completely calcium
bound (Rmax) and the ratio in calcium-free solution
(Rmin) were measured as previously described by exposing
vessels to buffer containing 5 mM CaCl2 or 0 CaCl2 and 0.5 mM EGTA, respectively, along with 10 µM
4-bromo-A-23187, a Ca2+ ionophore (25, 27).
Videomicroscopy and measurement of vessel diameters.
To quantify vasoconstriction, microperfusion experiments were captured
on videotape using a video camera (WV-BL90; Panasonic). Experiments
were recorded on a video cassette recorder (AG-1960; Panasonic)
equipped with a microphone for voice recording and were played back to
enable diameter measurement via calipers. As previously
described, changes in vessel outer diameter are expressed as percent
constriction (25, 27, 36).
Reagents.
DAF-2 DA (5 mM in DMSO) was purchased from Calbiochem (La Jolla, CA)
and stored at
20°C; it was diluted to 10 µM to load OMDVR. Sodium
nitroprusside (SNP), BK,
N
-nitro-L-arginine methyl ester
(L-NAME), L-arginine, and tempol were purchased
from Sigma. SNP was dissolved just before experimentation and was
protected from light. BK, L-NAME, and
L-arginine were dissolved in water and stored in 1 × 10
4 M, 100 mM, and 100 mM concentrations, respectively,
at
20°C and in 100-µl aliquots. Stock frozen solutions were
thawed on the day of the experiment, and the excess was discarded. In a manner similar to that described by Zou and colleagues (37, 38), human Hb2+ was purchased from Sigma as a
lyophilized powder and was dissolved in buffer on the day of experimentation.
Statistics.
Data are shown as means ± SE. Statistical testing employed
Student's t-test (paired or unpaired, as appropriate) and
ANOVA. With ANOVA, the Student-Newman-Keuls test was used to examine significance.
 |
RESULTS |
Reaction of DAF-2 with exogenous NO.
In the first series of experiments, we verified the ability of DAF-2
(loaded into isolated OMDVR) to increase fluorescence during exogenous
NO production by SNP. As shown in Fig. 3
(left), OMDVR loaded with DAF-2 increased
background-subtracted fluorescence by ~30% over 10 min. Time
controls showed a slow decline in fluorescence. The decline in signal
emitted from the controls cannot be interpreted as a lack of NO
generation but does imply that the rate of loss of the dye due to
leakage exceeded the rate of fluorescence increase due to basal rates
of NO generation.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 3.
Reaction of DAF-2 with NO from SNP. OMDVR were loaded
with DAF-2. Buffer containing SNP (0.95 mM) was exchanged into the bath
as DAF-2 fluorescence (F) was monitored. Left: data are
shown as means ± SE of F normalized to time 0 (F0). Right: summary and statistical comparison
of the differences between SNP and controls are shown. Data from the
final minute of observation have been normalized to the average of the
controls. Number of vessels tested is shown in parentheses.
*P < 0.05 controls vs. SNP.
|
|
The decline in fluorescence of controls in Fig. 3 illustrates several
important points. First, to successfully measure endogenous NO
generation with the dye, sufficient observation periods are required.
Second, the most meaningful statistical comparison occurs between
controls and the experimental group(s) at the end of the observation
period, at which point the integrated effects of NO reaction with DAF-2
are maximized. Thus we adopted the convention of analyzing the data by
the means illustrated in Fig. 3 (right). The final minute of
fluorescence was averaged for all control vessels, and this was used to
obtain a "normalized fluorescence" value (ordinate) for all
measurements in the control and experimental groups. This approach
forces the controls to a mean of unity yet enables presentation and
analysis of the variation of the data for statistical comparison.
Because dye leakage and experimental perturbations are sources of
variation, we maximized the sensitivity by always performing a
contemporary set of controls alternated vessel by vessel in the order
of study with the experimental groups.
The ability of exogenous generation of NO with SNP to shift the
absorption spectrum of Hb was also verified at various initial Hb2+ concentrations. For these experiments, SNP was
incubated with a portion of the Hb2+ solution until
complete conversion to the Hb3+ form occurred.
Subsequently, the absorption spectra were measured in the microcuvette
by alternately drawing in the Hb2+ and Hb3+
solutions at concentrations of 0-5 µM (see Fig. 2). As shown in
Fig. 4, A and B,
the expected absorbance shift with an isosbestic point at ~411 nm was
readily observed even in the small (~10 nl) volume of the cuvette.
Absorbance (A) was calculated from transmittance (T) using the standard formula A =
log
(T/T1), where
T1 is the transmittance in the absence of Hb.
The difference between Hb2+ and Hb3+ absorbance
was linear with Hb concentration at all wavelengths and was most
sensitive at 400 nm (increased absorbance) or 420 nm (reduced
absorbance), as shown in Fig. 4C. Exogenous production of NO
with SNP (0.5 mM) yielded the results shown in Fig. 4D where T, normalized to that at time 0 (T0), is shown as a function of time after
drawing SNP + Hb2+ solution (5 µM) into the cuvette.
The anticipated increase in transmittance at 420 nm was observed.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 4.
Conversion of Hb2+ to Hb3+ in the
microcuvette by SNP. A: transmittance as a function of
wavelength is shown for Hb concentrations of 0-5 µM. Spectral
shift with isosbestic point at 411 nm is observed. B: same
data as in A, converted to units of absorbance.
C: difference between absorbance of Hb2+ and
Hb3+ at various wavelengths is a linear function of Hb
concentration. Maximal changes are observed at 400 and 420 nm.
D: transmittance (T) is shown as a function of
time normalized to the value at time 0 (T0). Hb2+ solution containing SNP
was drawn into the cuvette and the oxidation process was monitored at
420 nm. Hgb, hemoglobin; [Hgb], hemoglobin concentration.
|
|
Endogenous production of NO: effects of L-arginine.
Measurement of endogenous NO production in DAF-2-loaded vessels proved
feasible but required longer observation periods than were employed
with SNP (see Fig. 3). We first asked whether the supply of the NO
synthase (NOS) substrate L-arginine affected basal NO
generation in this isolated vessel preparation. Overall DAF-2
fluorescence declined with time in control vessels that were not
supplied with L-arginine. As illustrated (see Fig.
5, left) and summarized (see
Fig. 5, right), addition of 0.1 mM L-arginine tended to enhance the DAF-2 signal compared with controls, but the
effect did not achieve significance (P = 0.08).
Addition of 1 mM L-arginine yielded a slightly increasing
signal that achieved significance compared with the controls
(P < 0.05; Fig. 5, right).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of L-arginine (L-Arg) bath on NO
generation by isolated OMDVR. Left: normalized change in
DAF-2 fluorescence as a function of time after introduction of
L-arginine into the bath at 0, 0.1, or 1.0 mM
concentrations. Right: comparison of the normalized average
of the last minute of data (means ± SE). Number of vessels tested
is shown in parentheses. *P < 0.05 vs.
L-arginine (0 mM).
|
|
Endogenous production of NO with BK.
To test the ability of the endothelium-dependent vasodilator BK to
stimulate NO production, vessels loaded with DAF-2 were exposed to a
bath containing 0.1 mM L-arginine with or without BK
(1 × 10
7 M). BK resulted in an enhancement of DAF-2
fluorescence compared with controls, but a relatively large number of
observations were required to achieve significance (see Fig.
6, A and B). NO
production was also examined at lower BK concentrations (1 × 10
10 and 5 × 10
9 M; n = 7 each). DAF-2 fluorescence was 99 and 102% of control, respectively, neither of which achieved significance. We also verified
that L-NAME (1 × 10
4 M) inhibits
BK-stimulated NO production (see Fig. 6, C and
D). The results during continuous excitation were similar to
those obtained when excitation light was blocked with a shutter during most of the experiment, which verified that dye leakage rather than
photobleaching accounted for the slow decline of the signal (see Fig.
6, E and F).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of bradykinin (BK) on NO generation by isolated
OMDVR. A: normalized change in DAF-2 fluorescence is shown
as a function of time after introduction into the bath of
L-arginine (0.1 mM) with or without BK (1 × 10 7 M). B: comparison of the normalized
average of the last minute of data from A (means ± SE). C: normalized change in DAF-2 fluorescence is shown as
a function of time after introduction of BK (1 × 10 7 M) + L-arginine (0.1 mM) with or
without N -nitro-L-arginine methyl
ester (L-NAME; 1 × 10 4 M) into the
bath. *P < 0.05 with vs. without BK. D:
comparison of the normalized average of the last minute of data from
C is provided (means ± SE). E and
F: experiment shown in C and D was
repeated except that excitation of DAF-2 was blocked with a shutter.
*P < 0.05 with vs. without L-NAME. Number
of vessels tested is shown in parentheses.
|
|
It is interesting to note that the majority of the BK-induced effect
occurred within the first 15 min after BK was introduced into the bath,
after which the signals for the control and the BK-treated groups
tended to decline in parallel (see Fig. 6). As shown in Fig.
7, the majority of the increase in
endothelial Ca2+ concentration (measured with fura 2 under
identical conditions) also occurred during this period, which possibly
accounts for the early potency of the BK effect. We also verified the
ability of BK to enhance NO production in isolated OMDVR with the Hb
assay. As illustrated in Fig. 8, addition
of L-NAME (1 × 10
4 M) blocked BK
(1 × 10
7 M)-stimulated NO production as monitored
by the transmittance at 420 nm.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 7.
Effect of BK on intracellular Ca2+
concentration ([Ca2+]i) in isolated
OMDVR. The [Ca2+]i response of fura
2-loaded OMDVR is shown as BK (1 × 10 7 M) is
introduced into the bath at time 0. Data are means ± SE of 9 vessels.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of L-NAME on BK-stimulated NO
production, measured by oxidation of Hb2+. T is
shown as a function of time normalized to the value at time
0. Hb2+ solution containing BK (1 × 10 7 M) was drawn into the cuvette with or without
L-NAME (1 × 10 4 M), and the oxidation
was process monitored at 420 nm. Data are means ± SE.
*P < 0.05 with vs. without L-NAME.
|
|
Effect of tempol on [NO] within isolated OMDVR.
Because oxygen free radicals are produced by a variety of endogenous
enzymes and consume NO, we tested the hypothesis that local [NO]
within cells of OMDVR would increase in the presence of a superoxide
dismutase mimetic. Tempol was chosen because it is cell permeant, and
it functions as a superoxide dismutase mimetic (10, 30).
Inclusion of tempol (1 mM) in the bath tended to enhance DAF-2
fluorescence compared with controls, but the effect did not achieve
significance (data not shown; P = 0.08;
n = 6 and 9 for controls and tempol, respectively).
When BK (1 × 10
7 M) was also used to stimulate NO
production, significant increases in DAF-2 fluorescence were readily
observed with tempol compared with unstimulated (P < 0.01) or BK-stimulated (P < 0.05) vessels (see Fig.
9). A series of experiments were also
performed to determine whether the addition of tempol (1 mM) would have
an effect on the ability of SNP (0.95 mM) to increase the fluorescence
of DAF-2 loaded into OMDVR. With tempol, fluorescence increased by
12.2 ± 1.3% in 10 min (n = 7). In the absence of
tempol, fluorescence increased by 7.7 ± 1.7% in 10 min
(n = 7; P = 0.06 vs. tempol). We also
tested the ability of tempol (1 mM) to dilate OMDVR that had been
preconstricted by ANG II (1 × 10
8 M). After we
obtained baseline diameter measurements, ANG II was added to the bath
for 5 min. Thereafter, either tempol or vehicle was exchanged into the
bath for 5 min and then washed out for 5 min. Tempol dilated
preconstricted vessels whether or not L-arginine (1 × 10
4 M) was included in the bath (see Fig.
10).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 9.
Effect of 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl
(tempol) on BK-stimulated NO generation of isolated OMDVR.
Left: normalized change in DAF-2 fluorescence as a function
of time after introduction of L-arginine (0.1 mM) alone
(control), L-arginine + BK (1 × 10 7 M), or L-arginine + BK (1 × 10 7 M) + tempol (1 mM). Right: comparison
of the normalized average of the last minute of data (means ± SE). Number of vessels tested is shown in parentheses.
*P < 0.05 BK with vs. without tempol;
**P < 0.01 BK + tempol vs. control.
|
|

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 10.
Effect of tempol on ANG II-induced vasoconstriction of
OMDVR. Isolated microperfused OMDVR were constricted with ANG II
(1 × 10 8 M). Percent constriction is shown at the
end of three sequential 5-min periods in which the bath was sham
exchanged (left), exchanged to introduce and then remove 1 mM tempol (middle), or exchanged to introduce and remove
tempol without L-arginine present in the bath
(right). *P < 0.05. NS, not significant.
|
|
 |
DISCUSSION |
Substantial evidence has been accumulated to show that perfusion
of the renal medulla is sensitive to blockade of NO synthesis. Systemic
infusion of L-arginine corrects abnormal pressure
natriuresis and medullary autoregulation in spontaneously hypertensive
rats (16, 18). Intravenous infusion of L-NAME
into conscious rats induces hypertension, sodium retention, and
reduction of medullary blood flow yet spares perfusion of the renal
cortex (24). Selective infusion of L-NAME into
the interstitium of the kidney of uninephrectomized rats also caused
both hypertension and the selective reduction of medullary blood flow
(20, 21). Hypertension was induced by the inhibition of
neural NOS (nNOS) expression via interstitial infusion of antisense
oligonucleotides or by inhibition of nNOS activity via interstitial
infusion of a selective inhibitor (19). Recent experiments
with the juxtamedullary nephron technique (12) confirmed
roles for nNOS in affecting responsiveness of the afferent arteriole
(due to alteration of tubuloglomerular feedback) and in affecting
efferent arteriolar constriction (via intrinsic effects).
The study of regulation by NO most often depends on observation of the
biological effects of nonspecific or isoform-specific NOS blockade. NO
generation at the level of single cells or groups of cells is difficult
to measure. Such measurements have been performed in isolated
microvessels and nephron segments with microelectrodes (33) and through the determination of the conversion of
L-[3H]arginine to citrulline by NOS
(35). Isolated OMDVR are very small microvessels
(diameter, 15 µm; length, 500 µm), respectively. As such, detection
of NO generation presents a similar challenge. In this study, we
investigated the feasibility of using the fluorescent probe DAF-2 for
this purpose. The dye successfully detected exogenous NO donation by
SNP (see Fig. 3) and endogenous NO production by OMDVR (see Figs. 5, 6,
and 9). The greatest limitation was the tendency of DAF-2 to leak from
the vessels after being trapped by deesterification. Our experience
with losses of fura 2 after loading of the OMDVR with the ester was
similar (25, 27). Fura 2 and similar probes are more
forgiving, because dual-wavelength ratios compensate for and hide the
effects of losses due to leakage. DAF-2 fluorescence is measured at a
single wavelength so that leakage is directly superimposed on the data
records. A competition between loss of signal due to leak and
enhancement of fluorescence by NO determines the maximum observation
time and therefore our overall ability to discern the effects of an
experimental perturbation. Also, the reaction of DAF-2 with NO produced
an irreversible covalent modification; therefore, repeated observations
on a single vessel could not be readily performed. In summary, to
measure the event of interest, sufficient NO modification of the dye
must occur on a time scale that is shorter than the rate of loss due to
leakage, and only group comparisons are possible. Despite this
difficulty, we found that properly designed studies with DAF-2 can
yield useful measurement of the modulation of NO generation in isolated OMDVR.
To provide independent verification of NO generation by another method,
we also adapted a microincubation scheme that allows conversion of
Hb2+ to Hb3+ by NO released from isolated
vessels (see Fig. 2). In this approach, the electron released by
Hb2+ to NO during the degradation causes a shift in the
absorption spectrum that is most efficiently monitored at either 400 or
420 nm (see Fig. 4) or by taking the difference between the
transmittance values at these two wavelengths (1,
23). Once again the method is feasible but difficult.
The greatest limitation is the simple inability to obtain stable
placement of the vessel(s) within the pipette holding area/cuvette.
Exchange of the volume of Hb2+ in the cuvette generally
dislodges or alters the location of the vessel so that repeated paired
comparisons cannot be meaningfully performed. The effects of Hb on
oxygen tension within the cuvette area are unknown and cannot be
readily controlled. In view of this, there is also concern that the
rapid local consumption of NO by Hb2+ might enhance
activation of NOS independent of the experimental perturbations.
Theoretically, variations in NO production due to manipulations that
occur more rapidly than the time required for diffusion of NO across
the cuvette might not be accurately measured, because diffusion away
from the vessel would dominate over NO production as the rate-limiting
step. This is unlikely to be a problem, because NO diffusivity
(D) is high. For D = 3,300 µm2/s at 37°C in water (15) and a cuvette
of diameter d = 50-100 µm, it is expected that a
characteristic diffusion time of
~d2/D = 3 s would exist.
Thus events occurring on a scale of minutes can be measured. In keeping
with this notion, we were able to document the blockade of NO
generation in BK-stimulated OMDVR (see Fig. 8). In general,
measurements with DAF-2 are easier to perform and do not suffer from
the concern over Hb activation. Our extensive use of DAF-2 in this
study reflects our preference for that method. The possibility of
extending either of these methods to the study of NO generation in
isolated nephron segments has not been explored but does seem inviting.
Intracellular L-arginine concentrations are reported
(2) to be in the range of 100-800 µM, which are
values that are much greater than the ~10 µM substrate requirement
of endothelial NOS. Based on this consideration, it is not anticipated
that high concentrations of L-arginine would affect the
rate of NO generation. In contrast, increasing the extracellular
concentration of L-arginine has been repeatedly shown
(6) to enhance NO generation; this finding has been dubbed
the "arginine paradox" (14). In a previous study (25), we showed that BK-induced vasodilation could be
augmented by including L-arginine in the bath of
microperfused OMDVR. The results illustrated in Fig. 5 support this
finding and verify that NO generation by isolated OMDVR can be enhanced
by L-arginine. It has been proposed (14) that
L-arginine might reside within intracellular pools
sequestered from NOS and that NOS isoforms could be spatially linked to
membrane L-arginine transporters. The finding that
L-arginine infusion can modulate medullary perfusion and
pressure natriuresis (16) coupled with the existence of L-arginine-facilitated transport systems in the medulla
(8) raise the possibility that specific recycling
mechanisms serve to regulate vasomotion of DVR within vascular bundles
through local alterations of interstitial L-arginine concentration.
It is generally accepted that NO is a short-lived molecule, the effects
of which are exerted within several micrometers of the site of
synthesis. Local levels of superoxide anion regulate the availability
of NO by reacting with NO to produce peroxynitrite (3, 7).
This process has been implicated in exaggerated vasoactivity in
spontaneously hypertensive rats (31) and has been shown to
affect vasoconstriction of the afferent arteriole in rabbits
(32). In support of the possibility that [NO] within the
OMDVR wall is also modulated by superoxide, we found that treatment
with the cell-permeant superoxide dismutase mimetic tempol
substantially augmented the detection of NO during BK stimulation (11, 31, 32) (see Fig. 9). Tempol also increased DAF-2
fluorescence when SNP was the NO donor (P = 0.06). The
latter finding is consistent with the hypothesis that tempol reduces
the consumption of SNP-donated NO by superoxide anion; however, a
specific effect on the release of NO from SNP by NADPH oxidase cannot
be ruled out (21). The functional significance of the
tempol effect was also investigated in ANG II-constricted OMDVR (see
Fig. 10); tempol vasodilated the preconstricted vessels whether or not
L-arginine was included in the bath.
We previously observed a tendency for ANG II to reduce endothelial
[Ca2+]i in fura 2-loaded OMDVR
(27). The ability of tempol to vasodilate OMDVR,
presumably through enhancement of [NO], implies that there is ongoing
NO production in the presence of ANG II. Another possibility is that
some NOS isoform is expressed within the pericytes where ANG II almost
certainly increases [Ca2+]i during
vasoconstriction. We previously observed (36) that nonspecific NOS inhibitors, when applied alone, constrict OMDVR. That
finding supports the functionally significant NO production in
unstimulated vessels.
In the absence of Hb and oxygen, the half-life of NO can be quite long
(3). A competing effect in this scenario is the requirement of oxygen as a substrate for NOS during NO generation from
L-arginine (34). Whether local NO levels would
tend to increase during hypoxia due to reduced destruction by
superoxide anion or decrease due to reduced NO generation resulting
from oxygen-substrate limitation is uncertain. The net result might depend locally on the expression and behavior of enzymes such as NADPH
oxidase that generate reactive oxygen species (7). The
potential interactions are clearly complex, however, given the low
PO2 (4) and the low Hb
concentration of blood within the renal medulla (26). The
possibility can be entertained that NO might accumulate to high levels
and diffuse far enough to have distant effects.
 |
ACKNOWLEDGEMENTS |
This work was supported by National Institutes of Health Grants
DK-42495 and HL-62220.
 |
FOOTNOTES |
Address for reprint requests and other correspondence:
T. L. Pallone, Div. of Nephrology, N3W143, Univ. of Maryland at
Baltimore, Baltimore, MD 21201-1595 (E-mail:
tpallone{at}medicine.umaryland.edu).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 29 August 2000; accepted in final form 14 February 2001.
 |
REFERENCES |
1.
Archer, S.
Measurement of nitric oxide in biological models.
FASEB J
7:
349-360,
1993[Abstract].
2.
Baydoun, AR,
Emery PW,
Pearson JD,
and
Mann GE.
Substrate dependent regulation of intracellular amino acid concentrations in cultured bovine aortic endothelial cells.
Biochem Biophys Res Commun
173:
940-948,
1990[ISI][Medline].
3.
Beckman, JS,
and
Koppenol WH.
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly.
Am J Physiol Cell Physiol
271:
C1424-C1437,
1996[Abstract/Free Full Text].
4.
Brezis, M,
Heyman SN,
Dinour D,
Epstein FH,
and
Rosen S.
Role of nitric oxide in renal medullary oxygenation. Studies in isolated and intact rat kidneys.
J Clin Invest
88:
390-395,
1991.
5.
Brown, LA,
Key BJ,
and
Lovick TA.
Bio-imaging of nitric oxide-producing neurons in slices of rat brain using 4,5-diaminofluorescein.
J Neurosci Methods
92:
101-110,
1999[ISI][Medline].
6.
Buckley, BJ,
Mirza Z,
and
Whorton AR.
Regulation of Ca2+ dependent nitric oxide synthase in bovine aortic endothelial cells.
Am J Physiol Cell Physiol
269:
C757-C765,
1995[Abstract/Free Full Text].
7.
Chagriya, K,
and
Wilcox CS.
Antioxidants for hypertension.
Curr Opin Nephrol Hypertens
7:
531-538,
1998[ISI][Medline].
8.
Dantzler, WH,
and
Silbernagl S.
Basic amino acid transport in renal papilla: microinfusion of Henle's loops and vasa recta.
Am J Physiol Renal Fluid Electrolyte Physiol
265:
F830-F838,
1993[Abstract/Free Full Text].
9.
Fenoy, FJ,
Ferrer P,
Carbonell L,
and
Garcia-Salom M.
Role of nitric oxide on papillary blood flow and pressure natriuresis.
Hypertension
25:
408-414,
1995[Abstract/Free Full Text].
10.
Hahn, SM,
Sullivan FJ,
DeLuca AM,
Bacher JD,
Liebmann J,
Krishna MC,
Coffin D,
and
Mitchell JB.
Hemodynamic effect of the nitroxide superoxide dismutase mimics.
Free Radic Biol Med
27:
529-535,
1999[ISI][Medline].
11.
Iannone, A,
Bini A,
Swartz HM,
Tomasi A,
and
Vannini V.
Metabolism in rat liver microsomes of the nitroxide spin probe tempol.
Biochem Pharmacol
38:
2581-2586,
1989[ISI][Medline].
12.
Ichihara, A,
Inscho EW,
Imig JD,
and
Navar LG.
Neuronal nitric oxide synthase modulates rat renal microvascular function.
Am J Physiol Renal Physiol
274:
F516-F524,
1998[Abstract/Free Full Text].
13.
Kojima, H,
Nakatsubo N,
Kikuchi K,
Urano Y,
Higuchi T,
Tanaka J,
Kudo Y,
and
Nagano T.
Direct evidence of NO production in rat hippocampus and cortex using a new fluorescent indicator: DAF-2 DA.
Neuroreport
9:
3343-3348,
1998.
14.
Kurz, S,
and
Harrison DG.
Insulin and the arginine paradox.
J Clin Invest
99:
369-370,
1997[ISI][Medline].
15.
Lancaster, JR, Jr.
Diffusion of free nitric oxide.
Methods Enzymol
268:
31-38,
1996[ISI][Medline].
16.
Larson, TS,
and
Lockhart JC.
Restoration of vasa recta hemodynamics and pressure natriuresis in SHR by L-arginine.
Am J Physiol Renal Fluid Electrolyte Physiol
268:
F907-F912,
1995[Abstract/Free Full Text].
17.
Lemley, KV,
and
Kriz W.
Cycles and separations: the histotopography of the urinary concentrating process.
Kidney Int
31:
538-548,
1987[ISI][Medline].
18.
Lockhart, JC,
Larson TS,
and
Knox FG.
Perfusion pressure and volume status determine the microvascular response of the rat kidney to N
-monomethyl-L-arginine.
Circ Res
75:
829-835,
1994[Abstract/Free Full Text].
19.
Mattson, DL,
and
Bellehumeur TG.
Neural NO synthase in the renal medulla and blood pressure regulation.
Hypertension
28:
297-303,
1996[Abstract/Free Full Text].
20.
Mattson, DL,
Lu S,
Nakanishi K,
Papanek PE,
and
Cowley AW, Jr.
Effect of chronic renal medullary nitric oxide inhibition on blood pressure.
Am J Physiol Heart Circ Physiol
266:
H1918-H1926,
1994[Abstract/Free Full Text].
21.
Mattson, DL,
Roman RJ,
and
Cowley AW, Jr.
Role of nitric oxide in renal papillary blood flow and sodium excretion.
Hypertension
19:
766-769,
1992[Abstract/Free Full Text].
22.
Mohazzab-H, KM,
Kaminski PM,
Agarwal R,
and
Wolin MS.
Potential role of a membrane bound NADH oxidoreductase in nitric oxide release and arterial relaxation to nitroprusside.
Circ Res
84:
220-228,
1999[Abstract/Free Full Text].
23.
Murphy, ME,
and
Noack E.
Nitric oxide assay using hemoglobin method.
Methods Enzymol
233:
240-250,
1994[ISI][Medline].
24.
Nakanishi, K,
Mattson DL,
and
Cowley AW, Jr.
Role of renal medullary blood flow in the development of L-NAME hypertension in rats.
Am J Physiol Regulatory Integrative Comp Physiol
268:
R310-R316,
1995.
25.
Pallone, TL,
Silldorff EP,
and
Cheung JY.
Response of isolated descending vasa recta to bradykinin.
Am J Physiol Heart Circ Physiol
274:
H752-H759,
1998[Abstract/Free Full Text].
26.
Pallone, TL,
Silldorff EP,
and
Turner MR.
Intrarenal blood flow: microvascular anatomy and the regulation of medullary perfusion.
Clin Exp Pharmacol Physiol
25:
383-392,
1998[ISI][Medline].
27.
Pallone, TL,
Silldorff EP,
and
Zhang Z.
Inhibition of calcium signaling in descending vasa recta endothelia by ANG II.
Am J Physiol Heart Circ Physiol
278:
H1248-H1255,
2000[Abstract/Free Full Text].
28.
Pallone, TL,
Work J,
Myers RL,
and
Jamison RL.
Transport of sodium and urea in renal outer medullary vascular bundles.
J Clin Invest
93:
212-222,
1994.
29.
Park, F,
Mattson DL,
Roberts LA,
and
Cowley AW, Jr.
Evidence for the presence of smooth muscle
-actin within pericytes of the renal medulla.
Am J Physiol Regulatory Integrative Comp Physiol
273:
R1742-R1748,
1997[Abstract/Free Full Text].
30.
Samuni, A,
Mitchell JB,
DeGraff W,
Krishna CM,
Samuni U,
and
Russo A.
Nitroxide SOD-mimics: modes of action.
Free Radic Res Commun
12:
187-194,
1991.
31.
Schnackenberg, GC,
Welch WJ,
and
Wilcox CS.
Normalization of blood pressure and renal vascular resistance in SHR with a membrane permeable superoxide dismutase mimetic. Role of nitric oxide.
Hypertension
32:
59-64,
1998[Abstract/Free Full Text].
32.
Schnackenberg, GC,
Welch WJ,
and
Wilcox CS.
TP receptor-mediated vasoconstriction in microperfused afferent arterioles: roles of O
· and NO.
Am J Physiol Renal Physiol
279:
F302-F308,
2000[Abstract/Free Full Text].
33.
Thorup, C,
Kornfeld M,
Winaver JM,
Goligorsky MS,
and
Moore LC.
Angiotensin II stimulates nitric oxide release in isolated perfused renal resistance arteries.
Pflügers Arch
435:
432-434,
1998[ISI][Medline].
34.
Whorton, AR,
Simonds DB,
and
Piantadosi CA.
Regulation of nitric oxide synthesis by oxygen in vascular endothelial cells.
Am J Physiol Lung Cell Mol Physiol
272:
L1161-L1166,
1997[Abstract/Free Full Text].
35.
Wu, F,
Park F,
Cowley AW, Jr,
and
Mattson DL.
Quantification of NO synthase activity in microdissected segments.
Am J Physiol Renal Physiol
276:
F874-F881,
1999[Abstract/Free Full Text].
36.
Yang, S,
Silldorff EP,
and
Pallone TL.
Effect of norepinephrine and acetylcholine on outer medullary descending vasa recta.
Am J Physiol Heart Circ Physiol
269:
H710-H716,
1995[Abstract/Free Full Text].
37.
Zou, AP,
Wu F,
and
Cowley AW, Jr.
Protective effect of angiotensin II induced increase in nitric oxide in the renal medullary circulation.
Hypertension
31:
271-276,
1997.
38.
Zou, AP,
and
Cowley AW, Jr.
Nitric oxide in renal cortex and medulla. An in vivo microdialysis study.
Hypertension
29:
194-198,
1997[Abstract/Free Full Text].
Am J Physiol Heart Circ Physiol 281(1):H316-H324
0363-6135/01 $5.00
Copyright © 2001 the American Physiological Society